Dr. Andre-Guy Martin
Claim this profileCHUdeQuebec
Studies Prostate Cancer
Studies Radiation Sickness
6 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Andre-Guy Martin is currently running
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting0 awards Phase 2
Ultra-Hypofractionated Radiotherapy + Brachytherapy
for Prostate Cancer
Phase 1-2 study, comparing ultra-hypofractionnated (UH) to a moderately hypofractionnated (MH) radiation therapy, with image guided HDR prostate brachytherapy. Using iso-equivalent doses, a non-inferiority analysis will be done in order to prove UH non-inferior to MH, toxicity wise. Acceptability, tolerability, acute and late toxicity will be reported. MRI visible dominant intra-prostatic lesion will be outlines and variability between radiation oncologists and radiologists will be reported. As secondary objective, biochemical and clinical failure free survival will be reported at 5 \& 10 years.
Recruiting1 award N/A
More about Andre-Guy Martin
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andre-Guy Martin has experience with
- HDR Brachytherapy Boost
- Hypofraction
- Standard
- Moderately Hypofractionnated Radiotherapy
- Ultra Hypofractionnated Radiotherapy
- Conventionally Fractionated IMRT With HDR Boost
Breakdown of trials Andre-Guy Martin has run
Prostate Cancer
Radiation Sickness
Radiotherapy Side Effects
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andre-Guy Martin specialize in?
Andre-Guy Martin focuses on Prostate Cancer and Radiation Sickness. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andre-Guy Martin currently recruiting for clinical trials?
Yes, Andre-Guy Martin is currently recruiting for 2 clinical trials in Quebec City Quebec. If you're interested in participating, you should apply.
Are there any treatments that Andre-Guy Martin has studied deeply?
Yes, Andre-Guy Martin has studied treatments such as HDR Brachytherapy Boost, Hypofraction, Standard.
What is the best way to schedule an appointment with Andre-Guy Martin?
Apply for one of the trials that Andre-Guy Martin is conducting.
What is the office address of Andre-Guy Martin?
The office of Andre-Guy Martin is located at: CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Quebec City, Quebec G1R 2J6 Canada. This is the address for their practice at the CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.